 |
ST1-RTA immunotoxin (SR 44163) |
|---|---|
| Trade Name | |
| Orphan Indication | Acute lymphoblastic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1987-08-12 00:00:00 |
| Sponsor | Sanofi Winthrop, Inc.;9 Great Valley Parkway;Malvern, Pennsylvania, 19355 |
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute Lymphoblastic Leukemia
ERYtech Pharma – Acute Lymphoblastic Leukemia
University of California, San Francisco – Acute lymphoblastic leukemia
ERYtech Pharma – Acute lymphoblastic leukemia
Amgen – Acute lymphoblastic leukemia